CORC

在结果中检索

CORC

浏览/检索结果: 共54条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
hASCs-derived exosomes rescuing rats with acute liver failure by releasing IncRNA H19 会议论文
作者:  Jin, Y.;  Li, H.;  Wang, X.;  Chen, C.;  Fu, Q.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 240 会议论文
作者:  Xu, J. -H.;  Jing, C. -D.;  Chen, X. -F.;  Wang, S.;  Zeng, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
ATTITUDES AND BEHAVIOR OF PATIENTS WITH GYNECOLOGIC MALIGNANCY TOWARDS SEXUAL ISSUES: A SINGLE-INSTITUTIONAL SURVEY 会议论文
作者:  Ye, S.;  Ma, Q.;  Chen, X.;  Wang, C.;  Zhang, Y.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Features of Idiopathic Membranous Nephropathy in Elderly Patients and Its Correlation with the Expression of PLA2R 会议论文
作者:  Liu, X. B.;  Zhang, Q. H.;  Zhang, Y.;  Chen, Y.;  Liu, S. J.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China 会议论文
作者:  Wu, X.;  Wang, J.;  Zhou, Q.;  Gu, T.;  Zhang, K.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace